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WILSON’S DISEASE IN PREGNANCY
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SUMMARY – Wilson’s disease is a rare autosomal recessive disorder of copper metabolism. It 
causes cirrhosis of the liver, consequently followed by disorder of the menstrual cycle and infertility. 
Successful decopperizing may lead to restoration of the ovulatory cycle and enable pregnancy. Incre-
ased copper levels may cause preeclampsia, intrauterine growth restriction and neurologic damages 
in the fetus. Pregnant women with decompensated liver cirrhosis face more complications, including 
bleeding from esophageal varices, liver failure, encephalopathy, and rupture of the splenic artery. We 
present a case of Wilson’s disease in a patient who had spontaneously conceived three times. The first 
pregnancy ended with delivery of a healthy baby at term. In second pregnancy, medically induced 
abortion was performed in the 12th week because of deterioration of the underlying disease, liver 
cirrhosis with portal hypertension. In the same year, the patient underwent liver transplantation. 
Two years after the transplantation, the patient spontaneously conceived and delivered vaginally a 
healthy child. 
Key words: Hepatolenticular degeneration; Liver cirrhosis; Pregnancy; Case report
Correspondence to: Žana Žegarac, MD, Merkur University Hos-
pital, Zajčeva 19, HR-10000 Zagreb, Croatia
E-mail: zanazegarac@yahoo.com
Received July 11, 2012, accepted September 26, 2012
Introduction
Wilson’s disease is a rare autosomal recessive dis-
order accompanied by disturbed copper metabolism. 
The dominant pathophysiological mechanism is cop-
per accumulation in certain organs, primarily in the 
liver and brain. The incidence ranges from 1:30 000 
to 1:100 000. Kinnier Wilson was the first to describe 
the disease in 19121. The disorder is most commonly 
manifested in the early twenties. Without appropri-
ate treatment, the chance for a successful pregnancy is 
notably decreased due to the impaired fertility caused 
by liver insufficiency2. Disturbed copper metabolism 
may be associated with preeclampsia and intrauter-
ine growth restriction3. Successful pregnancy is rare 
in patients with liver cirrhosis. The incidence of such 
pregnancies is unknown, since cirrhosis rarely affects 
women in their reproductive age. It is estimated to 45 
cases per 100 000 women of reproductive age. Cir-
rhosis of the liver results in hormonal and metabolic 
disorders, which may cause anovulatory cycles and 
amenorrhea4. 
Case Report
The patient was born in 1976. She was diagnosed 
with the hepatic type of Wilson’s disease in 1991. 
Since 1991, she had been on continuous therapy with 
d-penicillamine. In 2001, the patient conceived spon-
taneously for the first time. She delivered vaginally 
at term a healthy male child, 3050 g/52 cm. During 
and after the pregnancy, the patient had been treated 
with d-penicillamine. In 2003, the patient conceived 
spontaneously for the second time. The pregnancy was 
terminated in the 12th week because of portal hyper-
tension. Due to the advanced cirrhosis of the liver, the 
patient underwent liver transplantation in the same 
year. In 2005, two years after the transplantation, the 
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patient conceived spontaneously again. The pregnancy 
was uneventful. The results of all biochemical tests 
during pregnancy were normal, except for platelet 
count ranging from 49 to 85x109/L. Thrombocytope-
nia was also present before pregnancy, probably as a 
consequence of spleen enlargement. Abdominal ul-
trasonography showed normal blood flow through the 
portal vein and other hepatic vessels, and an enlarged 
spleen, 180x160 mm in size, with a venous convolute 
in the hilus. Ultrasound of the fetus was normal, with 
fetal growth and development appropriate for ges-
tational age. She gave birth to a healthy male child, 
4110 g/52 cm, in the 40th week of pregnancy. 
Discussion 
Wilson’s disease affects people all over the world, 
regardless of their sex, race or nationality1. The AT-
P7B gene, which is responsible for the occurrence of 
Wilson’s disease was discovered in 1993. It is located 
on the 13th chromosome. It codes the enzyme type P 
adenosine triphosphate, which is expressed mostly in 
hepatocytes. The enzyme is responsible for the trans-
membrane transport of copper in hepatocytes. The 
accumulation of copper in the liver is the result of a 
decreased hepatocellular excretion of copper to the 
gallbladder caused by the lacking or decreased func-
tion of ATP7B protein. There is over one hundred 
mutations of this gene, which may trigger the occur-
rence of Wilson’s disease5. Both parents must be carri-
ers of the pathological gene for Wilson’s disease to be 
inherited. If both parents carry the gene for Wilson’s 
disease, the probability for the child to develop Wil-
son’s disease is 25%1. 
When the capacity for storing copper in the liver is 
exceeded, copper appears in the bloodstream. Conse-
quently, it accumulates in other organs, most notably 
the brain, the kidneys and the cornea. The decreased 
function of ATP7B protein causes yet another prob-
lem. It is a disorder of copper implantation in the ce-
ruloplasmin, a protein that binds copper. Most of the 
copper from food becomes absorbed in the duodenum 
and proximal part of the small intestine. It binds to 
albumin and is transported to the liver through portal 
bloodstream. In the circulation system, 90% of cop-
per binds to ceruloplasmin. In the states of hypere-
strogenism, such as pregnancy, the concentration of 
ceruloplasmin is decreased6. Exceeded accumulation 
of copper primarily damages the liver and the brain, 
which results in development of liver diseases (45%-
58%), neuropsychiatric diseases (30%-33%), or both. 
The symptoms of Wilson’s disease most commonly 
appear in adolescence or in the twenties2. Our patient 
had experienced the first symptoms while an adoles-
cent. Before the first symptoms appear, there is a pe-
riod without any symptoms during which copper gets 
accumulated in the body. The manifested liver disease 
may range from unspecific hepatomegaly to serious 
cases of liver cirrhosis and acute liver failure7. Isolated 
splenomegaly due to the cirrhosis of the liver caused 
by portal hypertension may be perceived as one of the 
first symptoms6. The majority of patients with Wil-
son’s disease develop liver cirrhosis6.
About 40%-50% of patients with Wilson’s dis-
ease suffer from neuropsychiatric symptoms7. They 
can develop hepatic encephalopathy. Hepatic en-
cephalopathy is characterized by a wide spectrum of 
neuropsychological disturbances, ranging from sleep 
disorders, changes in personality, degradation of cog-
nitive functions, and of neural and motor functions8. 
Indicative of Wilson’s disease is the Kayser-Fleischer 
ring appearing on the cornea. It is a result of copper 
accumulation in the cornea and is reported in 60% of 
Wilson’s disease patients7. The Kayser-Fleischer ring 
affects 95% of patients suffering from neuropsychiat-
ric symptoms7. 
Compensated liver cirrhosis without portal hyper-
tension is not a contraindication for pregnancy5. Por-
tal hypertension increases the risk of complications for 
mothers5. The most important complications include 
bleeding from esophageal varices, which affects 18%-
32% of pregnant women with Wilson’s disease and 
50% of pregnant women with portal hypertension. 
Bleeding from esophageal varices is associated with a 
mortality rate of 50%. About 24% of pregnant women 
develop decompensation of liver disease, ascites and 
portal encephalopathy. Pregnant women with liver cir-
rhosis have a higher risk of the splenic artery rupture 
(2.6%) with consequent hypovolemic shock. Mater-
nal mortality rate in such cases is extremely high and 
is reported to be 70%. In comparison to the general 
population, decompensated liver cirrhosis increases 
the incidence of spontaneous abortion (30%-40% as 
opposed to 15%-20%) and premature labor (25%)4. 
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Due to liver cirrhosis with portal hypertension, our 
patient’s second pregnancy was terminated by a medi-
cally induced abortion in the 12th week of gestation. 
Only a few successful pregnancies in women with 
Wilson’s disease have been described. Chronic liver 
disease and toxicity of copper disturb menstrual cycle. 
Major problems are infertility and recurrent sponta-
neous abortions2. Recurrent spontaneous abortions 
are common in the first trimester. They are consid-
ered to be the consequence of accumulated copper 
in the uterus, especially when the patients have not 
been medically treated3. Sinha et al. demonstrated an 
increased prevalence of spontaneous abortions in un-
treated pregnant women with Wilson’s disease when 
compared with the treated ones9. Treated patients 
have a high probability of conceiving a child2. 
The increased copper levels may be related to the 
development of preeclampsia caused by copper accu-
mulation in the liver. It may also cause intrauterine 
growth restriction. The fetus may also suffer neuro-
logic damages, which are often a result of hypoxia 
caused by the accumulation of copper in the placenta 
and fetal tissue3.
Once diagnosed, Wilson’s disease has to be treated 
for life. The accumulated copper must be removed us-
ing chelating agents. Therapy consists of four medica-
tions: d-penicillamine, trientine, zinc salts and am-
monium tetrathiomolybdate, which are classified as 
Pregnancy Category C drugs by the Food and Drug 
Administration4.
The medications used for the treatment of Wilson’s 
disease are not contraindicated in pregnancy. Therapy 
most commonly used in pregnancy is d-penicillamine. 
It mobilizes tissue copper and increases its excretion 
by urine. It has been used since 1965. Numerous side 
effects of d-penicillamine have been reported in 30% 
of cases6. Side effects that occur within three weeks of 
commencing medication include lymphadenopathy, 
neutropenia and proteinuria, which can later be fol-
lowed by nephrotoxicity, a syndrome resembling lupus 
with hematuria, aplastic anemia and skin rash6. In the 
initial stage of treatment with d-penicillamine, neu-
rologic symptoms deteriorate in 10%-20% of cases6. 
Although considered to be a safe choice in preg-
nancy, in a small number of cases d-penicillamine has 
been reported to cause congenital malformations of the 
fetus, including fragile blood vessels, low positioned 
ears, micrognathia, and hyperflexy hips and joints3. 
Our patient had been treated with d-penicillamine 
and gave birth to a healthy child. The second most 
commonly used medication is zinc salt, which has 
been used since 1960. There are reportedly less side 
effects than with d-penicillamine therapy, with no de-
terioration of neurologic symptoms. Zinc salt is as ef-
fective as d-penicillamine and patients tolerate it bet-
ter. Trientine has been used since 1969. It is similar to 
d-penicillamine, but has a less potent effect. Ammo-
nium tetrathiomolybdate is a strong chelating agent. It 
does not cause deterioration of neurologic symptoms6. 
Cessation of the drug treatment may cause an acute 
liver failure6. In comparison to the dose of chelating 
agents (d-penicillamine and trientine) taken before 
pregnancy, the dose should be reduced by 25%-50% 
during pregnancy. It is of utmost importance in the 
third trimester if cesarean section is to be performed. 
A lower dose of chelating agents speeds up the heal-
ing process. There is no need to reduce the dose of 
zinc salts6. Liver transplantation is the first-line ther-
apy for patients with fulminating disease and those 
suffering from decompensated liver cirrhosis. Clinical 
manifestations may improve during pregnancy due to 
the increased copper need of the fetus and quadruple 
ceruloplasmin level in pregnant women10. 
Our patient had spontaneously conceived and gave 
birth to a healthy male child ten years after being di-
agnosed with the hepatic type of Wilson’s disease. 
The patient had been treated with d-penicillamine. 
The patient’s second spontaneous pregnancy was ter-
minated in the 12th week by a medically induced abor-
tion due to deterioration of liver cirrhosis with portal 
hypertension. In the same year, the patient underwent 
liver transplantation. Two years after the transplanta-
tion, the patient spontaneously conceived and gave at 
term birth to a healthy child.
Conclusion
Wilson’s disease is a rare congenital disease. Spon-
taneous abortions are common in untreated patients. 
Treated patients have a high probability of getting 
pregnant and giving birth to a child. Pregnant wom-
en with decompensated cirrhosis of the liver are at a 
greater risk of developing complications during preg-
nancy. Liver transplantation is the first-line therapeu-
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tic option for patients suffering from decompensated 
liver disease. These pregnancies demand intense mon-
itoring and team work in order to achieve a successful 
outcome for both the mother and the child. 
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Sažetak
WILSONOVA BOLEST U TRUDNOćI
Ž. Žegarac, Ž. Duić, S. Stasenko, J. Zmijanac Partl, J. Valetić i V. Čolić Cvrlje
Wilsonova bolest je rijedak autosomno recesivni poremećaj metabolizma bakra. Uzrokuje cirozu jetre te posljedično 
poremećaj menstruacijskog ciklusa i infertilitet. Uspješna dekuprinizacija može dovesti do ponovne pojave ovulacijskih 
ciklusa i omogućiti trudnoću. Povećane vrijednosti bakra mogu uzrokovati preeklampsiju, intrauterini zastoj u rastu te 
neurološka oštećenja ploda. Trudnoća kod trudnica s dekompenziranom cirozom jetre povećava komplikacije kod majke, 
uključujući krvarenje iz varikoziteta jednjaka, zatajenje jetre, encefalopatije i rupture lijenalne arterije. Prikazuje se bo-
lesnica s Wilsonovom bolešću koja je tri puta spontano zanijela. Prva trudnoća okončana je porodom zdravog djeteta u 
terminu. Druga trudnoća prekinuta je u 12. tjednu medicinski induciranim pobačajem zbog pogoršanja osnovne bolesti, 
ciroze jetre s portalnom hipertenzijom. Iste godine u bolesnice je učinjena transplantacija jetre, a dvije godine nakon tran-
splantacije spontano je zanijela i vaginalno rodila zdravo dijete.
Ključne riječi: Hepatolentikularna degeneracija; Trudnoća; Jetrena ciroza; Prikaz slučaja
